Grant Creates New Wallace H. Coulter Center for Translational Research |
||||||||||||||||
Sports Legends Raise Millions for Miami Project | ||||||||||||||||
Macdonald Foundation Grant Funds New Genecure Diagnostics Lab | ||||||||||||||||
he ability to fast-track promising research from scientific laboratories to patients’ bedsides is taking a giant leap forward at the Miller School of Medicine, thanks to a gift from the Wallace H. Coulter Foundation. The $13 million grant establishes the Wallace H. Coulter Center for Translational Research at the Miller School, focusing on breakthrough treatments for diabetes, cancer, arthritis, spinal cord injury, and paralysis, along with other advances in biomedical technologies. Over the years most federal and private funding for medical research has focused on either basic science research or clinical research, with little attention paid to translating basic science to the clinical level. Even less attention has been focused on biomedical product development. The Wallace H. Coulter Center for Translational Research hopes to change that equation. “This is an extraordinarily generous gift to support something of great importance,” says Luis Glaser, Ph.D., executive vice president and provost of the University. “The National Institutes of Health have called on academic medical centers to concentrate more on translational activities, and this gift will help put us at the forefront of that mission.” The research projects will originate within five centers of excellence at the Miller School of Medicine and the College of Engineering: the Diabetes Research Institute, Sylvester Comprehensive Cancer Center, The Miami Project to Cure Paralysis, Bascom Palmer Eye Institute, and the Department of Biomedical Engineering. In the new center, scientists will have access to resources and investigators who can help them design human trials to test their discoveries and turn them into patented products. Cancer vaccines, certain diagnostic tests, and even cell-based therapies for diabetes and other disorders are examples of products that could make their way to patients faster. The center is under the direction of Norma Kenyon, Ph.D. Kenyon holds the Martin Kleiman Chair in Diabetes Research, is a professor of surgery, medicine, microbiology, and immunology, and is director of preclinical islet transplantation and co-director of the Cell Transplant Center at the Diabetes Research Institute. |
||||||||||||||||
|
||||||||||||||||
Macdonald Foundation Grant
Funds New Genecure Diagnostics Lab DNA-Driven Medicine hrough a $5 million grant from the Dr. John T. Macdonald Foundation, the Miller School of Medicine is creating Miami GeneCure Diagnostics, Florida’s first comprehensive medical genetics diagnostic laboratory. GeneCure will perform genetic diagnostic testing to determine human susceptibility to diseases, with a goal of preventing those diseases whenever possible. “The success of the Human Genome Project has already led to important diagnostic breakthroughs and will in the near future result in entirely new approaches to prevent many devastating diseases,” says Louis J. Elsas, M.D., director of the Dr. John T. Macdonald Foundation Center for Medical Genetics at the Miller School. The concept of genetic diagnostics is based on predictive testing of DNA, its protein products, and body chemicals produced by protein functions. Given these diagnostic tools, prevention is possible through individualized medications, avoidance of environmental toxins, nutritional adjustment, and implementation of replacement therapy for insufficient gene products. The Miami GeneCure Diagnostic Laboratory will be composed of the newly created molecular and biomedical genetics laboratories and the cytogenetics laboratory that already exists in the Division of Medical Genetics, Department of Pediatrics. It will be the first genetic diagnostic testing laboratory in Florida. GeneCure will help create biotech companies in the community that will take intellectual property research from the University’s faculty and put it into practice. The Coral Gables-based Dr. John T. Macdonald Foundation Inc. supports and promotes health care and the welfare of the community. |
||||||||||||||||
|
||||||||||||||||
y all accounts, Jean Fiegelman, an elementary school teacher from Pittston, Pennsylvania, and her husband, Harry, a jeweler, lived very modest lives. They retired to Florida in the 1960s and settled in North Miami Beach, keeping the same condo for nearly four decades. They had no children, rarely traveled, and placed their savings in a variety of stocks and bonds. Harry died in 1988 at age 82, and Jean passed away in February 2004 at age 95. Her will revealed that the Fiegelmans had left the bulk of their $8 million estate—$5 million—to the University of Miami Miller School of Medicine to fund scholarships for “worthy medical students regardless of their race, religion, sex, or national origin.” John G. Clarkson, M.D., senior vice president for medical affairs and dean of the Miller School of Medicine, says, “The Fiegelmans’ gift came as a complete surprise. She obviously cared very deeply about the next generation of doctors and the financial burdens caused by the high cost of attending medical school. “Jean Fiegelman dreamed about being able to make a difference. Her remarkable generosity is an investment in the future of our school that will help assure her dream will come true.” The Jean B. and Harry L. Fiegelman Scholarship is the medical school’s single largest bequest for student scholarships. Jean Fiegelman’s nephew, Steven Zelkowitz of Miami, says, “She was always philanthropic. She got it from her mother and father. We had no idea how generous she was until she passed away.” He added that the family doesn’t know why Fiegelman chose the medical school to receive the bulk of her estate. Steven Brooks, vice president and trust officer with Bank of America Private Bank, says, “Mrs. Fiegelman never put on airs. She was generous with family members and charities and donated to medical research in the United States and Israel.” |
||||||||||||||||
|
||||||||||||||||
n March 8 the University of Miami Leonard M. Miller School of Medicine recognized 45 organizations that have shown a strong commitment to the medical school’s missions of research, patient care, education, and community service. These Partners In Caring (PIC) were honored at a luncheon recognizing their long-term support of the medical school. More than 250 people attended the luncheon at Miami’s J.W. Marriott Hotel. Norman Braman, co-chair of the Miller School of Medicine’s Momentum campaign and chair of the Medical Affairs Committee of the University of Miami Board of Trustees, announced that the 45 Partners In Caring have collectively raised $120 million toward the medical school capital campaign. To date the medical school has raised $539 million of the current University campaign total of $861 million. “Thanks to the PIC we are changing the face of the University of Miami Miller School of Medicine and health care as we know it,” Braman said. “Whether it’s developing new therapies for curing deafness or treating cancer, we stand at the threshold of beating some of mankind’s greatest enemies. And so much of this progress is directly related to the work of Partners In Caring.” John G. Clarkson, M.D., senior vice president for medical affairs and dean of the Miller School of Medicine, noted, “None of the medical school’s recent accomplishments, from securing major campaign investment to creating strategic alliances, would have happened without the strong foundation of philanthropic support provided by our Partners In Caring.” |
||||||||||||||||
ALUMNISPOTLIGHT|KENNETH ROTHENBERG, M.D. ’67 | ||||||||||||||||
|
||||||||||||||||
|